Altasciences Chosen by Respira Technologies, Inc. as Drug Product Manufacturing Partner for the World’s First Inhaled Nicotine Replacement Therapy (NRT)
Altasciences ’ pharmaceutical contract manufacturing site in Philadelphia, PA, has been chosen by Respira Technologies, Inc. to manufacture proprietary drug products for the world’s first inhaled smoking cessation therapy. This treatment uses RespiRx™, a vibrating mesh nebulizer (VMN) with a maintenance-free disposable cartridge that reduces and potentially eliminates the risk of patient misuse and non-compliance.
Following a successful Pre-Investigational New Drug (IND) meeting with the Food and Drug Administration (FDA) on November 18, Respira is intending to submit their IND application in 2022 under the 505(b)(2) regulatory pathway.
Respira also plans to create a larger platform approach for active pharmaceutical ingredient (API) delivery, taking advantage of the multi-drug capabilities of their proprietary platform drug delivery system. To date, 91 potential APIs have been identified.
“Our team chooses best-in-class partners, and working with Altasciences has been a great experience overall. Altasciences is playing a big role in advancing Respira’s ambition to secure the FDA’s authorization on a potential breakthrough drug product, and through this collaborative environment, we can change the world of drug development. Altasciences is agile, flexible, and quick, while providing the proven expertise and capability required for cGMP pharma drug product manufacturing. We are thankful for their fast response rate, creativity, and ability to take on the needs of nimble start-ups like Respira ,” said Mario Danek, Founder and CEO at Respira Technologies, Inc.
Altasciences leverages deep expertise in formulation, development, and manufacturing, as well as flexible processes and significant investments in state-of-the-art technologies, to support clients in their research and commercial manufacturing requirements.
“We are delighted to be partnering with Respira Technologies, Inc. on this new and exciting technology. Our team has truly enjoyed having the opportunity to work with a world-class organization that quickly makes key decisions to ensure we meet accelerated timelines,” stated Ben Reed, Executive Vice President of Operations at Altasciences.
More information on Respira Technologies, Inc.’s program can be found here .
Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services . For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing , clinical pharmacology and proof of concept , bioanalysis , program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-THEOREMONE25.1.2022 00:39:08 CET | Press release
Theorem, LLC Announces Rebrand to TheoremOne with the Acquisition of Formula Partners, Launch of Lemma
JAPAN-PRIZE-FOUNDATION25.1.2022 00:32:07 CET | Press release
The Japan Prize Foundation: 2022 Japan Prize Laureates Announced
TX-MOUSER-ELECTRONICS24.1.2022 20:12:08 CET | Press release
Mouser Partners with DRAGON / PENSKE AUTOSPORT Formula E Racing for 8th Straight Season
FERRONATO-KGS-GROUP24.1.2022 17:52:12 CET | Press release
Swiss Tech Major, FERRONATO KGS GROUP, Launches Metallised Lifestyle Smart Accessories Brand At EXPO 2020 DUBAI
CO-AEM24.1.2022 14:07:04 CET | Press release
AEM Announces Major Upgrade to the Earth Networks Total Lightning Network®
MA-EXAGRID24.1.2022 14:02:12 CET | Press release
New ESG Technical Review Highlights Unique ExaGrid Tiered Backup Storage Cost Savings Benefits for Commvault Environments with a 3:1 Increase in Data Deduplication
VA-HILTON24.1.2022 14:02:12 CET | Press release
Hilton Celebrates Growth and Development Milestones as Company Prepares for a New, Reinvigorated Era of Travel
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom